Abstract
Background and Purpose Chronic hemiparetic stroke patients have very limited benefits from current therapies. Brain-computer interface (BCI) engaging the unaffected hemisphere has emerged as a promising novel therapeutic approach for chronic stroke rehabilitation. This study investigated the effectiveness of the IpsiHand System, a contralesionally-controlled BCI therapy in chronic stroke patients with impaired upper extremity motor function. We further explored neurophysiological features of motor recovery affected by BCI. We hypothesized that BCI therapy would induce a broad motor recovery in the upper extremity (proximal and distal), and there would be corresponding changes in baseline theta and gamma oscillations, which have been shown to be associated with motor recovery.
Methods Thirty chronic hemiparetic stroke patients performed a therapeutic BCI task for 12 weeks. Motor function assessment data and resting state electroencephalogram (EEG) signals were acquired before initiating BCI therapy and across BCI therapy sessions. The Upper Extremity Fugl-Meyer assessment (UEFM) served as a primary motor outcome assessment tool. Theta-gamma cross-frequency coupling (CFC) was computed and correlated with motor recovery.
Results Chronic stroke patients achieved significant motor improvement with BCI therapy. We found significant improvement in both proximal and distal upper extremity motor function. Importantly, motor function improvement was independent of Botox application. Theta-gamma CFC enhanced bilaterally over the C3 and C4 motor electrodes following BCI therapy. We observed significant positive correlations between motor recovery and theta gamma CFC increase across BCI therapy sessions.
Conclusions BCI therapy resulted in significant motor function improvement across the proximal and distal upper extremities of patients. This therapy was significantly correlated with changes in baseline cortical dynamics, specifically theta-gamma CFC increases in both the right and left motor regions. This may represent rhythm-specific cortical oscillatory mechanism for BCI-driven motor rehabilitation in chronic stroke patients.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT03611855
Funding Statement
This work was supported by National Institutes of Health (NIH) R21NS102696 (E.C.L. and A.C.) and National Institute of Biomedical Imaging and Bioengineering (NIBIB) P41-EB018783 (E.C.L.).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Washington University School of Medicine in St. Louis gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data are available upon reasonable request to the corresponding author.
